Oryzon Genomics SA Cash Flow Quality Index
Oryzon Genomics SA cash flow quality index. Oryzon Genomics SA (ORY) has a Cash Flow Quality Index of -2.29x as of June 2023. Operating cash flow of €-2.41 Million is below net income of €1.05 Million, suggesting accrual-heavy earnings not yet converted to cash. See Oryzon Genomics SA free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Oryzon Genomics SA (2014–2014)
Cash flow quality index of Oryzon Genomics SA from 2014 to 2014. Historical Cash Flow Quality Index for Oryzon Genomics SA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore ORY debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Oryzon Genomics SA Cash Flow Quality Index by Year (2014–2014)
Oryzon Genomics SA cash flow quality index by year from 2014 to 2014. Year-by-year earnings quality comparison for Oryzon Genomics SA. For the full cash flow conversion analysis, see how efficiently does Oryzon Genomics SA generate cash.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2014 | 1.82x | €12.13 Million | €6.65 Million | — |